US district court blocks FDA's efforts to reclassify certain medical devices as drugs
This article was originally published in Clinica
A US district court has issued a decision which legal experts say will effectively prevent the Food and Administration from implementing new product classification rules that could have resulted in numerous medical products previously classified as devices to be reclassified as drugs.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.